Sign Up Today and Learn More About Hemab Stock
Invest in or calculate the value of your shares in Hemab or other pre-IPO companies through EquityZen's platform.
Hemab Stock (HEMB)
Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.
About Hemab Stock
Founded
2017
Industries
Software, Artificial Intelligence, Data and Analytics
Hemab Press Mentions
Stay in the know about the latest news on Hemab
StockWatch: enGene Shares Crater on Declines in Complete Response Rates to Bladder Cancer Therapy
genengnews • May 12, 2026
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
globenewswire • May 05, 2026
Hemab prices $301M in latest upsized biopharma IPO
bioworld • May 02, 2026
Hemab Therapeutics sets terms for $200 million IPO
thepharmaletter • May 02, 2026
Avalyn seeks $300m from its IPO
pharmaphorum • May 01, 2026
Hemab Management
Leadership team at Hemab
Board Member
Dan Becker
CTO & Co-Founder
Johan H. Faber
Join now and verify your accreditation status to gain access to:
- Hemab Current Valuation
- Hemab Stock Price
- Hemab Management
- Available deals in Hemab and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Hemab Cap Table and Funding History by Share Class and Liquidity Preferences
- Hemab Revenue and Financials
- Hemab Highlights
- Hemab Business Model
- Hemab Risk Factors
- Hemab Research Report from SACRA Research
Trading Hemab Stock
How to invest in Hemab stock?
Accredited investors can buy pre-IPO stock in companies like Hemab through EquityZen funds. These investments are made available by existing Hemab shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Hemab stock?
Shareholders can sell their Hemab stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
